1. Thongprayoon C, Tantrachoti P, Phatharacharukul P, et al. Associated immunological disorders and cellular immune dysfunction in thymoma: a study of 87 cases from Thailand. Arch Immunol Ther Exp (Warsz), 2013, 61(1): 85-93.
[2]
3. Bretti S, Berruti A, Loddo C, et al. Multimodal management of stages III-IVa malignant thymoma. Lung Cancer, 2004, 44(1): 69-77.
2. Detterbeck FC, Parsons AM. Management of stage I and II thymoma. Thorac Surg Clin, 2011, 21(1): 59-67.
[7]
4. Fujii Y. Thymus, thymoma and myasthenia gravis. Surg Today, 2013, 43(5): 461-466.
[8]
5. Shelly S, Agmon-Levin N, Altman A, et al. Thymoma and autoimmunity. Cell Mol Immunol, 2011, 8(3): 199-202.
[9]
8. Gamanagatti S, Sharma R, Hatimota P, et al. Giant thymolipoma. Am J Roentgenol, 2005, 185(1): 283-284.
[10]
9. Krawczyk P, Adamczyk-Korbel M, Kieszko R, et al. Immunological system status and the appearance of respiratory system disturbances in thymectomized patients. Arch Immunol Ther Exp (Warsz), 2007, 55(1): 49-56.
[11]
11. Horinouchi H, Asakura K, Kimura Y, et al. Prognosis of surgically treated thymic epithelial tumors. Nihon Geka Gakkai Zasshi, 2006, 107(6): 262-267.